Financhill
Back

Nektar Therapeutics Stock Price Chart

  • The current trend is moderately bullish and NKTR is experiencing slight buying pressure.

Nektar Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 70.41 Sell
20-day SMA: 59.93 Buy
50-day SMA: 48.17 Buy
200-day SMA: 40.37 Buy
8-day EMA: 68.46 Sell
20-day EMA: 61.99 Buy
50-day EMA: 54.28 Buy
200-day EMA: 42.61 Buy

Nektar Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 7.2 Buy
Relative Strength Index (14 RSI): 64.38 Buy
Chaikin Money Flow: 55297 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.72 - 71.86) Buy
Bollinger Bands (100): (41.82 - 64.4) Buy

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Nektar Therapeutics Stock

Is Nektar Therapeutics Stock a Buy?

NKTR Technical Analysis vs Fundamental Analysis

Buy
58
Nektar Therapeutics (NKTR) is a Buy

Is Nektar Therapeutics a Buy or a Sell?

Nektar Therapeutics Stock Info

Market Cap:
1.2B
Price in USD:
68.36
Share Volume:
884.8K

Nektar Therapeutics 52-Week Range

52-Week High:
75.67
52-Week Low:
6.48
Buy
58
Nektar Therapeutics (NKTR) is a Buy

Nektar Therapeutics Share Price Forecast

Is Nektar Therapeutics Stock a Buy?

  • Nektar Therapeutics share price is 68.36 while NKTR 8-day exponential moving average is 68.46, which is a Sell signal.
  • The stock price of NKTR is 68.36 while Nektar Therapeutics 20-day EMA is 61.99, which makes it a Buy.
  • Nektar Therapeutics 50-day exponential moving average is 54.28 while NKTR share price is 68.36, making it a Buy technically.
  • NKTR stock price is 68.36 and Nektar Therapeutics 200-day simple moving average is 42.61, creating a Buy signal.

Fundamental Analysis of Nektar Therapeutics

Is Nektar Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $2.76 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.36 per share, and a decrease next year of $2.17 per share.

Technical Analysis of Nektar Therapeutics

Should I short Nektar Therapeutics stock?

* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.